UPCOMING EVENTS: AAOS - March 14-18 | BASK - March 14-18 | BBA - May 4-6 | EWMA - May 4-6
Offering new options in woundcare and the use of human derived Allografts.
AvoMed are working on the product development and commercialisation plans of several soon to be launched projects in this space.
The Advanced Wound Care Market is expected to reach USD 14.9 billion by 2020 and is estimated to grow at a CAGR of 7.0% from 2015 to 2020.
Advanced wound care products are used when the standard wound care treatment fails. Treatment in advanced wound care involves interventions therapies and products, such as collagen products, NPTW antimicrobial dressings, foam dressings, gauze, hydrocolloids, film dressings, hydrogels, composites, and alginate dressings, among others.
Geographically, the North America advanced wound care market contributed 34.4%market share in 2014. The European market was valued at USD 3.2 billion in 2014, and is expected to grow at a CAGR of 6.8% from 2015 to 2020. In terms of high growth potential, the U.K. advanced wound care market is an open market, expected to witness growth at the fastest rate from 2015 to 2020.
The global advanced wound care market is expected to grow due to the rising aging population, growing incidences of diabetes, and technological advancements. However, the high cost of advanced wound care products act as a major restraining factor.
